Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor
Dina Polosukhina(Vanderbilt University Medical Center), Peter E. Clark(Levine Cancer Institute), Roy Zent(Vanderbilt University), Harold L. Moses(National Center for Toxicological Research), Ethan Lee(Johns Hopkins University), Harold D. Love(Vanderbilt University Medical Center)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
July 11, 2017
Cited by 11
Related Papers
The structure of the G protein heterotrimer Giα1β1γ2
|Cell|1995|1.1k
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
|The Journal of Cell Biology|1990|741
The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway
|PLoS Biology|2003|724
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
|Nature Chemical Biology|2010|488